Patents by Inventor Ralf Jager

Ralf Jager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190239548
    Abstract: Some embodiments relate to nutritional supplements comprising rice protein isolate. Some embodiments of the nutritional supplement comprise less than about 90 mg of leucine per gram of rice protein isolate and less than about 50 mg of lysine per gram of rice protein isolate. Some embodiments pertain to methods of using the nutritional supplements described herein to achieve one or more of weight gain, weight maintenance, growth, muscle growth, muscle maintenance, decreased muscle loss, or improved exercise training results.
    Type: Application
    Filed: February 12, 2019
    Publication date: August 8, 2019
    Inventors: David Janow, Ralf Jäger
  • Patent number: 10251415
    Abstract: Some embodiments relate to nutritional supplements comprising rice protein isolate. Some embodiments of the nutritional supplement comprise less than about 90 mg of leucine per gram of rice protein isolate and less than about 50 mg of lysine per gram of rice protein isolate. Some embodiments pertain to methods of using the nutritional supplements described herein to achieve one or more of weight gain, weight maintenance, growth, muscle growth, muscle maintenance, decreased muscle loss, or improved exercise training results.
    Type: Grant
    Filed: July 19, 2017
    Date of Patent: April 9, 2019
    Assignee: Axiom Foods, Inc.
    Inventors: David Janow, Ralf Jäger
  • Publication number: 20180243345
    Abstract: The present invention relates to methods for conferring mTOR mediated physiological benefits by administering a composition having phospholipids, omega-3 fatty acids, and an antioxidant, or a krill extract to a mammal in need thereof.
    Type: Application
    Filed: August 22, 2016
    Publication date: August 30, 2018
    Inventors: David McCray PEELE, Ralf JÄGER, Martin PURPURA
  • Publication number: 20170340572
    Abstract: The disclosed are shelf-stable beta-hydroxyisovaleric acid containing soft gel compositions and methods for making such compositions. In certain aspects, disclosed compositions comprise a plant-based capsule shell and a liquid formulation comprising beta-hydroxyisovaleric acid and at least one excipient, wherein the soft gel capsule is shelf-stable. In certain aspects, the excipient is selected from selected from choline salt, betaine, phosphatidylcholine, alpha-glycerophosphocholine, carnitine, adenosine 5?-triphosphate, or a combination thereof.
    Type: Application
    Filed: May 25, 2017
    Publication date: November 30, 2017
    Inventors: Martin Purpura, Ralf Jager, Jie Gu, Xiong Zheng, lingwei dai, Yaohua Zhang
  • Patent number: 9820504
    Abstract: Some embodiments relate to nutritional supplements comprising rice protein isolate. Some embodiments of the nutritional supplement comprise less than about 90 mg of leucine per gram of rice protein isolate and less than about 50 mg of lysine per gram of rice protein isolate. Some embodiments pertain to methods of using the nutritional supplements described herein to achieve one or more of weight gain, weight maintenance, growth, muscle growth, muscle maintenance, decreased muscle loss, or improved exercise training results.
    Type: Grant
    Filed: March 21, 2014
    Date of Patent: November 21, 2017
    Assignee: Axiom Foods, Inc.
    Inventors: David Janow, Ralf Jäger
  • Publication number: 20170318852
    Abstract: Some embodiments relate to nutritional supplements comprising rice protein isolate. Some embodiments of the nutritional supplement comprise less than about 90 mg of leucine per gram of rice protein isolate and less than about 50 mg of lysine per gram of rice protein isolate. Some embodiments pertain to methods of using the nutritional supplements described herein to achieve one or more of weight gain, weight maintenance, growth, muscle growth, muscle maintenance, decreased muscle loss, or improved exercise training results.
    Type: Application
    Filed: July 19, 2017
    Publication date: November 9, 2017
    Inventors: David Janow, Ralf Jäger
  • Publication number: 20170079311
    Abstract: A method for improving the absorption of amino acids from protein sources include adding one or more carbohydrases to a protein source. Plant protein such as that found in rice may be extracted to provide a rice concentrate useful in regimens requiring elevated amounts of protein consumption. To improve the absorption of the amino acids found in rice inside the human gastrointestinal tract, a carbohydrases such as Alpha-galactidase is added to the protein source prior to ingestion. The composition may also include proteases.
    Type: Application
    Filed: September 17, 2015
    Publication date: March 23, 2017
    Inventors: Ralf Jager, Mark Olson, Joseph P. Mannion, Jaroslav Boublik, Martin Purpura
  • Publication number: 20120141448
    Abstract: Phosphatidic acid is administered orally to increase muscle mass and strength in exercising mammals. Phosphatidic acid is administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. The preferred form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine is co-administered orally to increase the muscle-building and strength effect. Other suggested additives include nutritional and herbal supplements, micronutrients and hormones.
    Type: Application
    Filed: November 23, 2011
    Publication date: June 7, 2012
    Inventors: Lorenzo De Ferra, Marvin Heuer, Scott Hagerman, Martin Purpura, Ralf Jäger
  • Patent number: 8129360
    Abstract: The invention concerns the use of phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof for the treatment of the attention deficit syndrome (ADHS) in small daily doses over a longer time period and in larger daily doses over a short period as well as in combination with suitable additives selected from the group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters or/and phospholipids. In this connection it is preferred to carry out the administration to probands aged 2 to 20 years preferably 3 to 10 years whereby the phosphatidylserine as well as the additives are used in solid and also in liquid formulations. Due to its positive properties phosphatidyl-serine is in particular suitable as a therapeutic agent or food supplement in connection with ADHS. The good tolerance of phosphatidylserine even in high doses and over a longer supplementation period and the excellent compliance should also be stressed.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: March 6, 2012
    Assignee: Cargill Texturizing Solutions Deutschland GmbH & Co., KG
    Inventors: Ralf Jäger, Dirk Bökenkamp
  • Patent number: 8124594
    Abstract: Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels in subjects in need thereof are disclosed herein. The methods can be useful for subjects having age related decline in testosterone, exercise induced decline in testosterone, and/or hypogonadism.
    Type: Grant
    Filed: November 30, 2008
    Date of Patent: February 28, 2012
    Assignee: Chemi Nutra, LLC
    Inventors: Martin Purpura, Ralf Jäger, Scott L. Hagerman
  • Patent number: 7678768
    Abstract: The present invention concerns a physiologically active composition which contains an enzymatically hydrolysed collagen as the active component I and at least one component of the non-vitamin type having anti-oxidative and/or anti-inflammatory properties as the active component II. Collagen of animal origin that is soluble in cold water comes into particular consideration as component I and a fermentation broth or a plant extract comes into particular consideration as component II. This composition which is designed in particular as a food supplement or functional food can be used to prevent inflammatory and/or degenerative symptoms in particular with a chronic course such as for example arthritis and arthroses or to successfully treat these symptoms. The claimed composition can be used above all by professional, leisure and recreational athletes who suffer in particular from strained joint functions.
    Type: Grant
    Filed: July 27, 2005
    Date of Patent: March 16, 2010
    Assignee: Cargill Incorporated
    Inventors: Martin Purpura, Ralf Jäger, Karim Balan, Dietrich Paper
  • Publication number: 20090142425
    Abstract: A physiologically active composition is claimed which comprises effective amounts of at least one compound from the group 4-O-methyldavidigenin, 4?-O-methyldavidigenin, davidigenin, elemicin, isoelemicin, herniarin, demethoxycapillarisin, in particular 6-demethoxycapillarisin and/or 6-demethoxy-3?-methoxy-capillarisin, hispiludin and 9-hydroxy-10E, 12Z, 15Z-octadecatrienoic acid, and also glycosides thereof, in particular glucosides and/or rhamnoglucosides of 4-O-methyldavidigenin and/or 4?-O-methyldavidigenin, salts and derivatives.
    Type: Application
    Filed: July 21, 2005
    Publication date: June 4, 2009
    Inventors: Ralf Jager, Hans-Henning Wenk, Heike Tom Dieck, Hans Ullrich Hoppe, Roland Rabeler
  • Publication number: 20090143339
    Abstract: Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels in subjects in need thereof are disclosed herein. The methods can be useful for subjects having age related decline in testosterone, exercise induced decline in testosterone, and/or hypogonadism.
    Type: Application
    Filed: November 30, 2008
    Publication date: June 4, 2009
    Inventors: Martin Purpura, Ralf Jager, Scott L. Hagerman
  • Publication number: 20090005322
    Abstract: The present invention concerns a physiologically active composition which contains an enzymatically hydrolysed collagen as the active component I and at least one component of the non-vitamin type having anti-oxidative and/or anti-inflammatory properties as the active component II. Collagen of animal origin that is soluble in cold water comes into particular consideration as component I and a fermentation broth or a plant extract comes into particular consideration as component II. This composition which is designed in particular as a food supplement or functional food can be used to prevent inflammatory and/or degenerative symptoms in particular with a chronic course such as for example arthritis and arthroses or to successfully treat these symptoms. The claimed composition can be used above all by professional, leisure and recreational athletes who suffer in particular from strained joint functions.
    Type: Application
    Filed: July 27, 2005
    Publication date: January 1, 2009
    Inventors: Martin Purpura, Ralf Jager, Karim Balan, Dietrich Paper
  • Publication number: 20070009590
    Abstract: This physiologically active composition contains, as physiologically active constituents, the components a) phosphatidylserine and/or lysophosphatidylserine (in each case “PS”) and b) at least one (lyso)phospholipid different from component a) and c) a serine source different from component a), for example L-serine and/or O-phospho-L-serine. In this composition, the components a) and also b) and c) must each be present in a molar ratio a:b (where b<c) and a:c (where c<b) such that the components b) and c) can preferably form PS in vivo and in this manner ideally replace 10 to 99% by weight of the PS portion in the total formulation. The component a) should here make up 0.1 to 20% by weight of the total formulation and the components b) and c) should be present in portions between 15 and 65% by weight and in portions between 0.1 and 5.0% by weight, respectively.
    Type: Application
    Filed: September 3, 2004
    Publication date: January 11, 2007
    Inventors: Martin Purpura, Ralf Jager, Roland Rabeler, Hans-Ullrich Hoppe
  • Publication number: 20060280843
    Abstract: The present invention comprises a filler material for a container having at least one compartment, which container is situated in a pressurized beverage container and, immediately after the beverage container is opened, is suitable for mixing the filling into the drinks liquid surrounding the container. The filling itself is in granule form of defined particle diameter and is composed, in particular, of the main component a) in the form of a food supplement and an effervescent component b). The component a) which should be present in the filling in amounts of between 35 and 98% by weight can also be pharmaceutical active ingredients, vitamins, creatine derivatives, phospholipids, probiotics, minerals, unsaturated fatty acids and any desired mixtures thereof.
    Type: Application
    Filed: May 10, 2006
    Publication date: December 14, 2006
    Inventors: Ralf Jager, Martin Purpura, Reinhard Kroner
  • Publication number: 20060263486
    Abstract: The subject of the present invention relates to a filler material for a container having at least one chamber which is situated in a beverage container under pressure and immediately after the opening of the beverage container is suitable for the admixture of the filler material into the beverage liquid surrounding it. The filler material itself is in granule form and is composed of the chief component a) in the form of a nutritional supplement and an effervescent component b). The component a), which should be present in the filler material in percentages between 35 and 98 wt.-%, can be non-prescription agents, vitamins, creatine derivatives, phospholipids, probiotics, minerals, unsaturated fatty acids and any mixtures thereof. The fillers can be put into beverage liquids with varying pH, since due to their dissolving ability and due to the targeted selection of appropriate effervescence and bursting components can be dissolved quickly and completely in the beverage liquid.
    Type: Application
    Filed: May 18, 2005
    Publication date: November 23, 2006
    Inventors: Ralf Jager, Martin Purpura, Reinhard Kroner
  • Publication number: 20050220857
    Abstract: The invention concerns a physiologically compatible, phospholipid-containing, stable and hard matrix consisting of a supporting material and a bioactive component which has a total diameter of between 0.1 and 5000 ?m and contains ?5% by weight, based on the starting material, of acetone-insoluble components as the bioactive component, which are in particular phosphatidyl serine, phosphatidyl choline and such like, as well as lyso variants and/or derivatives thereof. This matrix which preferably has a supporting material consisting of carbohydrates and/or proteins and preferably additional bioactive substances as ingredients such as amino acids, vitamins, trace elements and similar substances, can have liquid contents and is used in particular in functional foods, special foods and dietary supplements.
    Type: Application
    Filed: April 17, 2003
    Publication date: October 6, 2005
    Inventors: Martin Purpura, Dirk Cremer, Ralf Jager, Michaela Thalhammer
  • Publication number: 20050175763
    Abstract: The claimed functional foods and specialized foods each contain a physiologically compatible phospholipid-containing stable matrix consisting of a supporting material and a bioactive component, the phospholipid component being in particular phosphatidyl serine, phosphatidyl choline and similar compounds, lyso variants and/or derivatives thereof. Liquid, solid and semiliquid forms of administration are preferred as the functional foods; food for tube feeding is regarded as preferred among the specialized foods. The matrix used for this should preferably have liquid contents and in particular have a diameter between 0.1 ?m and 5.0 mm. It is also preferred when the matrix develops a delayed release after its ingestion with the respective foods which should preferably take place in the gastro-intestinal tract.
    Type: Application
    Filed: April 17, 2003
    Publication date: August 11, 2005
    Inventors: Martin Purpura, Dirk Cremer, Ralf Jager, Michaela Thalhammer
  • Publication number: 20050096392
    Abstract: The invention relates to the use of creatine pyruvate for increasing stamina during highly intensive intermittent physical exertion. Said use is to be applied in particular during short-term intensive muscular exertion and/or muscular exertion of short-duration and/or that is repeated in short intervals, preferably during sprinting and sporting performances in running disciplines and during exercises using sports equipment provided with rollers, wheels or sliding surfaces, in addition to during raising, pulling and/or lifting movements of the extremities and the neck. The invention relates in particular to variants, in which muscular exertion is maintained for between 0.1 seconds and 5 minutes and/or during which the muscular exertion is carried out with a frequency of between 0.1 and 600 minutes. In the latter variant, the muscular exertion can increase with each interval.
    Type: Application
    Filed: April 3, 2003
    Publication date: May 5, 2005
    Inventors: Ralf Jager, Martin Purpura, Dirk Bokenkamp